ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "BILAG"

  • Abstract Number: 614 • 2012 ACR/ARHP Annual Meeting

    Predictors of Systemic Lupus Erythematosus Flares: Baseline Disease Activity and Demographic Characteristics From the Combined Placebo Groups in the Phase 3 Belimumab Trials

    Ronald F. van Vollenhoven1, Michelle Petri2, Roger A. Levy3, Sandra V. Navarra4, Jill P. Buyon5, Z. John Zhong6, William W. Freimuth6 and Ricard Cervera7, 1Karolinska University Hospital, Stockholm, Sweden, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Internal Medicine, Univ Estado Do Rio De Janeiro, Rio de Janeiro, Brazil, 4University of Santo Tomas Hospital, Manila, Philippines, 5Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 6Human Genome Sciences, Inc., Rockville, MD, 7Autoimmune Diseases, Hospital Clínic of Barcelona, Barcelona, Spain

    Background/Purpose: Predicting which SLE patients are at increased risk for clinically meaningful flares may be useful in making management decisions. The purpose of this analysis was to…
  • Abstract Number: 1420 • 2012 ACR/ARHP Annual Meeting

    Ethnicity and B Cell Depletion Therapy in Systemic Lupus Erythematosus

    A. Lois-Iglesias1, J. Ishorari2 and D.A. Isenberg2, 1Rheumatology, University Hospital Ramón y Cajal, Madrid, Spain. University College London, London, United Kingdom, 2Centre for Rheumatology, University College London, London, United Kingdom

    Background/Purpose:The aim of this study was to determine if there is any relation between ethnicity and outcome in  patients with SLE treated with B cell…
  • Abstract Number: 1418 • 2012 ACR/ARHP Annual Meeting

    Directed Intuitive Assessment of Lupus (the DIAL system for real world clinics) Correlates Well with BILAG and SLEDAI

    Anca D. Askanase1, Katrina M. Shum1, Stan Kamp2, Fredonna C. Carthen2, Teresa J. Aberle3 and J.T. Merrill2, 1NYU School of Medicine, New York, NY, 2Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis & Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Disease activity measures used in SLE clinical studies, including the SLEDAI (SLE Disease Activity Index) and BILAG (British Isles Lupus Assessment Group) index are…
  • Abstract Number: 2621 • 2012 ACR/ARHP Annual Meeting

    Sustained Disease Improvement and Safety Profile Over 1745 Patient-Year Experience (7 years) with Belimumab in Systemic Lupus Erythematosus Patients

    Joan T. Merrill1, Richard A. Furie2, Daniel J. Wallace3, William Stohl4, W. Winn Chatham5, Arthur Weinstein6, James D. McKay, Ellen M. Ginzler8, Z. John Zhong9, William W. Freimuth9 and Michelle Petri10, 1Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2North Shore-LIJ Health System, Lake Success, NY, 3Cedars-Sinai Medical Center, Los Angeles, CA, 4Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA, 5University of Alabama at Birmingham, Birmingham, AL, 6Washington Hospital Center, Washington, DC, 7Rheumatology, SUNY-Downstate Medical Center, Brooklyn, NY, 8Human Genome Sciences, Inc., Rockville, MD, 9Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: To update belimumab safety and efficacy data over 7 y in patients with active SLE.  Methods: 449 SLE patients with SELENA-SLEDAI scores ≥4 were enrolled…
  • « Previous Page
  • 1
  • 2
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.